Acquisition

Date: September 17, 2026 National Stock Exchange of India Ltd. Plaza, C 1, Block G, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051, Maharashtra, India. Company Symbol: QMSMEDI ISIN: INE0FMW01018 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we would like to inform you that QMS Medical Allied Services Limited (the Company) has made further investments by acquiring additional stake of 24% in Saarathi Healthcare Private Limited, a Subsidiary of the Company. Pursuant to the said acquisition, QMS Medical Allied Services Limited ("the Company") now holds 100% equity share capital of Saarathi Healthcare Private Limited and accordingly, Saarathi Healthcare Private Limited has become a wholly owned subsidiary of the Company. The details required to be furnished in compliance with Regulation 30 read with Schedule III Part A, Para A, Point 1 of SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as Annexure A: The aforesaid information is being made available on the Company's website i.e. https://qmsmas.com/ Kindly take the intimation on record and acknowledge receipt of the same. Yours truly, FOR QMS MEDICAL ALLIED SERVICES LIMITED TORAL BHADRA COMPANY SECRETARY MEMBERSHIP NO.: A56927 DATE: SEPTEMBER 17, 2026 PLACE: MUMBAI CIN: L33309MH2017PLC299748; Email ID: mm@qmsmas.com “Annexure – A” Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. Sr. Particulars Details a) Name of the target entity, details in brief such as Name of the Target Company: Saarathi size, turnover etc. Healthcare Private Limited Brief Details: The Target Entity is a subsidiary company of QMS Medical Allied Services Limited (“the Company”). The Company has increased its equity holding from 76% to 100 % (an increase of 24 %) in the Target Entity. The total paid-up Equity Share Capital of Target Entity as of date is Rs. 82.50/- (in Lakhs) and the turnover of Target Entity for the financial year ended March 31, 2026, is Rs. 1844.99/- (in Lakhs). The Company is engaged in the business of running Disease management, early diagnosis, screening with POC devices and otherwise, disease awareness, access programs across therapy by using digital tools as well as physical interaction models. (“Business”) b) whether the acquisition would fall within related No party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length”; c) Industry to which the entity being acquired Healthcare Services belongs d) Objects and impact of acquisition (including but In line with our key strategic priorities, not limited to, disclosure of reasons for acquisition the transaction will further expand QMS of target entity, if its business is outside the main Medical Allied Services Limited total line of business of the listed entity) addressable market in the value-added of Healthcare business. e) Brief details of any governmental or regulatory Not Applicable CIN: L33309MH2017PLC299748; Email ID: mm@qmsmas.com approvals required for the acquisition f) Indicative period for completion of the acquisition Pursuant to the said acquisition, QMS Medical Allied Services Limited ("the Company") now holds 100% equity share capital of Saarathi Healthcare Private Limited and accordingly, Saarathi Healthcare Private Limited has become a wholly owned subsidiary of the Company. g) Consideration - whether cash consideration or Cash Consideration share swap or any other form and details of the same h) Cost of acquisition and/or the price at which the 1,98,000 shares at Rs. 14,22,50,000/- shares are acquired i) Percentage of shareholding / control acquired and 24% leading to 100% in total / or number of shares acquired j) Brief background about the entity acquired in Saarathi Healthcare Private Limited is terms of products/line of business acquired, date engaged in the business of running of incorporation, history of last 3 years turnover, Disease management, early diagnosis, country in which the acquired entity has presence screening with POC devices and and any other significant information (in brief) otherwise, disease awareness, access programs across therapy by using digital tools as well as physical interaction models. (“Business”). The Company was incorporated on October 21, 2010 is headquartered at Thane, Maharashtra Details of last 3 years’ turnover: 2025-2026: 1844.99 Lakhs 2024-2025: 1629.47 Lakhs 2023-2024: 1332.51 Lakhs CIN: L33309MH2017PLC299748; Email ID: mm@qmsmas.com